Journal News

Harnessing a natural plant insecticide for commercial use

Elisabeth Adkins Marnik
June 25, 2024

Many plants produce molecules or peptides that help them combat destructive insects. These natural insecticides hold a lot of promise for improving how we can protect crops around the world from pests without harming the environment 

Developing plant insecticides into eco-friendly products is one area of interest in David Craik’s laboratory, which is part of the Institute for Molecular Bioscience at the University of Queensland, Brisbane, Queensland, Australia.

Craik’s lab identified a group of cyclotides in a prior study and found that they have natural insecticidal properties. Cyclotides are unique; unlike typical peptides that form linear chains of amino acids, cyclotides link together end to end to form circular peptides. These cyclopeptides can interact with specific phospholipids that form cell membranes. This can happen within the insect’s gut and cause cell swelling or lysis that results in death or growth restriction of the insect. The Craik lab has become interested in studying the applications of these cyclotides, particularly as potential pesticides.

In their recent study, conducted in collaboration with Syngenta Crop Protection AG, an international agriculture technology company, and published in the Journal of Biological Chemistry, Craik’s lab focused on a specific cyclotide known as kalata B1. For an insecticide to have broad use, a business must be able to manufacture it efficiently and cost-effectively. It must also remain stable in a variety of environmental conditions where factors such as temperature and pH may differ considerably.

To address these issues, the Craik lab mutated specific amino acids within the cyclotide to determine their impact on the molecule's stability under varying conditions. This was achieved through a technique called a lysine scan, where each amino acid within the cyclotide was systematically replaced with lysine. The researchers then evaluated whether the change enhanced the stability of the cyclopeptide.

This work enabled the lab to create a more stable cyclopeptide capable of targeting insect cells from the fall armyworm, a major pest worldwide. They also confirmed that they could manufacture this cyclopeptide efficiently and safely.

“We can actually use a natural recombinant process to produce these proteins,” Craik said. “Some types of peptide synthesis can be quite an environmentally unfriendly process in terms of the amount of waste materials produced. But if you can produce peptides, and then cyclize them using enzymes rather than chemicals, you have a much greater production pathway.”

As of now, the only other cyclotide insecticide on the market is one known as Sero-x. Approved for use in Australia, it is applied to cotton plants and certain vegetable crops.

The next step for the Craik lab is to feed the cyclotide insecticide to fall armyworms and determine if it is effective in killing them. If these trials prove successful, another cyclotide insecticide may soon be available for use.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Elisabeth Adkins Marnik

Elisabeth Adkins Marnik is the Director of Science Education & Outreach at the MDI Biological Laboratory in Bar Harbor, Maine, where she is spearheading the development of new programming. This work is driven by her passion for making science accessible to students and the public. She is an ASBMB Today volunteer contributor as well as the Chief Scientific Officer of Those Nerdy Girls. Follow her on Instagram @sciencewhizliz.
 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.